Effects of subchronic malathion exposure on the pharmacokinetic disposition of pefloxacin

Environmental Toxicology and Pharmacology

Volumn 22, Issue 2, 2006, Pages 167-171

  Suresh Babu, N ^a   Malik, J K ^a   Rao, G S ^a   Aggarwal, Manoj ^a   Ranganathan, V ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Chickens; Malathion; Pefloxacin; Pharmacokinetics

Indexed keywords

MALATHION; PEFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; MEAN RESIDENCE TIME; NONHUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALIA; AVES; GALLUS GALLUS; PEDICULUS HUMANUS CORPORIS;

EID: 33745942771     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2006.03.001     Document Type: Article

References (28)

1. Adgate J.L., Barr D.B., Clayton C.A., Eberly L.E., Freeman N.C., Lioy P.J., Needham L.L., Pellizzari E.D., Quackenboss J.J., Roy A., and Sexton K. Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ. Health Persp. 109 (2001) 583-590
2. Brown S.A. Fluoroquinolones in animal health. J. Vet. Pharmacol. Ther. 19 (1996) 1-14
3. Buratti F.M., D'Aniello A., Volpe M.T., Meneguz A., and Testai E. Malathion bioactivation in the human liver: the contribution of different cytochrome P450 isoforms. Drug Metab. Dispos. 33 (2005) 295-302
4. Butler A.M., and Murray M. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. J. Pharmacol. Exp. Ther. 280 (1997) 966-973
5. Davies B.I., and Maesen F.P. Drug interactions with quinolones. Rev. Infect. Dis. Suppl. 5 (1989) S1083-S1090
6. Elston D.M. Controversies concerning the treatment of lice and scabies. J. Am. Acad. Dermatol. 46 (2002) 794-796
7. Hazarika A., Sarkar S.N., Hajare S., Kataria M., and Malik J.K. Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study. Toxicology 185 (2003) 1-8
8. Humbert G., Brumpt I., Montay G., Le Liboux A., Frydman A., Borsa-Lebas F., and Moore N. Influence of rifampin on the pharmacokinetics of pefloxacin. Clin. Pharmacol. Ther. 50 (1991) 682-687
9. Isea G., Martinez M.A., Martinez Larranaga M.R., Diaz M.J., and Anadon A. Pharmacokinetic characteristics of pefloxacin and its metabolite N-demethyl pefloxacin in chickens. J. Vet. Pharmacol. Ther. 26 Suppl. 1 (2003) 113-114
10. John S., Kale M., Rathore N., and Bhatnagar D. Protective effect of vitamin E in dimethoate and malathion induced oxidative stress in rat erythrocytes. J. Nutr. Biochem. 12 (2001) 500-504
11. Johnson V.J., Rosenberg A.M., Lee K., and Blakley B.R. Increased T-lymphocyte dependent antibody production in female SJL/mice following exposure to commercial grade malathion. Toxicology 170 (2002) 119-129
12. Kwong T.C. Organophosphate pesticides: biochemistry and clinical toxicology. Ther. Drug Monit. 24 (2002) 144-149
13. MacIntosh D.L., Kabiru C.W., and Ryan P.B. Longitudinal investigation of dietary exposure to selected pesticides. Environ. Health Persp. 109 (2001) 145-150
14. Malik J.K., Rao G.S., Ramesh S., Muruganandan S., Tripathi H.C., and Shukla D.C. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration. Vet. Res. Commun. 26 (2002) 141-149
15. Maroni M., Colosio C., Ferioli A., and Fait A. Biological monitoring of pesticide exposure: a review. Toxicology 143 (2000) 1-118
16. Masoud L., Vijayasarathy C., Fernandez-Cabezudo M., Petroianu G., and Saleh A.M. Effect of malathion on apoptosis of murine L929 fibroblasts: a possible mechanism for toxicity in low dose exposure. Toxicology 185 (2003) 89-102
17. Montay G., and Tassel J.P. Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue. J. Chromatogr. 339 (1985) 214-218
18. Nielsen P., and Gyrd-Hansen N. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacol. Toxicol. 80 (1997) 246-250
19. Nigg H.N., and Knaak J.B. Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure. Rev. Environ. Contam. Toxicol. 163 (2000) 29-111
20. Overstreet D.H., and Djuric V. A genetic rat model of cholinergic hypersensitivity: implications for chemical intolerance, chronic fatigue, and asthma. Ann. N. Y. Acad. Sci. 933 (2001) 92-102
21. Petri Jr. W.A. Antimicrobial agents (continued): sulfonamides, trimethoprim-sulfamethoxazole, quinolones and agents for urinary tract infections. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (2001), McGraw-Hill, New York 1179-1183
22. Pournourmohammadi S., Farzami B., Ostad S.N., Azizi E., and Abdollahi M. Effects of malathion subchronic exposure on rat skeletal muscle glucose metabolism. Environ. Toxicol. Pharmacol. 19 (2005) 191-196
23. Roberts R.J. Clinical practice. Head lice. N. Engl. J. Med. 346 (2002) 1645-1650
24. Sanyal P.K. Disposition kinetics of albendazole in buffalo and cattle. J. Vet. Pharmacol. Ther. 20 (1997) 240-242
25. Savage E.P., Keefe T.J., Wheeler H.W., Mounce L., Helwic L., Applehans F., Goes E., Goes T., Mihlan G., Rench J., and Taylor D.K. Household pesticide use in the United States. Arch. Environ. Health 36 (1981) 304-309
26. Srikanth N.S., and Seth P.K. Alterations in xenobiotic metabolizing enzymes in brain and liver of rats coexposed to endosulfan and malathion. J. Appl. Toxicol. 10 (1990) 157-160
27. Storm J.E., Rozman K.K., and Doull J. Occupational exposure limits for 30 organophosphate pesticides based on inhibition of red blood cell acetylcholinesterase. Toxicology 150 (2000) 1-29
28. Varshneya C., Bahga H.S., and Sharma L.D. Effect of dietary malathion on hepatic microsomal drug-metabolizing systems of Gallus domesticus. Toxicol. Lett. 31 (1986) 107-111